Quadrant Capital Group LLC Repligen Corp Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Repligen Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 481 shares of RGEN stock, worth $69,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
481
Previous 390 23.33%
Holding current value
$69,485
Previous $49,000 44.9%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$119.79 - $167.35 $10,900 - $15,228
91 Added 23.33%
481 $71,000
Q2 2024

Aug 12, 2024
SELL
$120.0 - $182.95 $44,160 - $67,325
-368 Reduced 48.55%
390 $49,000
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $18,615 - $22,717
109 Added 16.8%
758 $139,000
Q4 2023

Feb 08, 2024
BUY
$114.17 - $185.35 $9,704 - $15,754
85 Added 15.07%
649 $116,000
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $29,282 - $37,243
211 Added 59.77%
564 $89,000
Q2 2023

Aug 09, 2023
SELL
$138.42 - $180.31 $51,492 - $67,075
-372 Reduced 51.31%
353 $49,000
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $20,362 - $26,149
132 Added 22.26%
725 $122,000
Q4 2022

Feb 10, 2023
SELL
$162.42 - $220.56 $20,464 - $27,790
-126 Reduced 17.52%
593 $100,000
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $55,505 - $88,648
346 Added 92.76%
719 $135,000
Q2 2022

Aug 09, 2022
BUY
$140.68 - $188.02 $24,619 - $32,903
175 Added 88.38%
373 $61,000
Q1 2022

May 06, 2022
SELL
$161.19 - $257.96 $322 - $515
-2 Reduced 1.0%
198 $38,000
Q4 2021

Feb 01, 2022
SELL
$247.59 - $304.47 $4,704 - $5,784
-19 Reduced 8.68%
200 $53,000
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $12,075 - $20,101
62 Added 39.49%
219 $63,000
Q2 2021

Aug 09, 2021
SELL
$165.87 - $220.95 $6,137 - $8,175
-37 Reduced 19.07%
157 $31,000
Q1 2021

May 12, 2021
BUY
$180.37 - $226.26 $7,395 - $9,276
41 Added 26.8%
194 $38,000
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $888 - $1,239
6 Added 4.08%
153 $29,000
Q3 2020

Nov 13, 2020
SELL
$122.51 - $158.27 $6,860 - $8,863
-56 Reduced 27.59%
147 $22,000
Q2 2020

Aug 13, 2020
SELL
$94.33 - $140.48 $99,612 - $148,346
-1,056 Reduced 83.88%
203 $25,000
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $1,529 - $1,964
18 Added 1.45%
1,259 $121,000
Q2 2019

Jul 24, 2019
BUY
$54.2 - $85.95 $65,040 - $103,140
1,200 Added 2926.83%
1,241 $105,000
Q2 2017

Aug 15, 2017
BUY
N/A
41
41 $0

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email